Hs 889.T細胞 
	
		運輸方式:	凍存運輸
	
	
		ATCC Number:	CRL-7626?
	
	
		相關**:	骨肉瘤
	
	
		年限:	14 years
	
	
		生長狀態:	貼壁生長
	
	
		器官來源:	骨
	
	
		是否是腫瘤細胞:	1
	
	
		物種來源:	人
	
	
		數量:	大量
	
	
		細胞形態:	混合型
	
	
		Designations:	Hs 889.T
	
	
		Hs 889.T細胞Biosafety Level:	1
	
	
		Shipped:	frozen
	
	
		Medium & Serum:	See Propagation
	
	
		Growth Properties:	adherent
	
	
		Organism:	Homo sapiens
	
	
		Morphology:	mixed
	
	
		
	
	
		Source:	Organ: bone
	
	
		Disease: osteosarcoma
	
	
		Permits/Forms:	In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
	
	
		Age:	14 years
	
	
		Gender:	male
	
	
		Ethnicity: Hs 889.T細胞Caucasian
	
	
		Comments:	Part of the NBL Cell Line Collection. This cell line is neither produced nor fully characterized by ATCC . We do not guarantee that it will maintain a specific morphology, purity, or any other property upon passage.
	
	
		Please see the NBL Repository description.
	
	
		Propagation:	ATCC complete growth medium: The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%.
	
	
		Temperature: 37.0°C
	
	
		Subculturing:	Subcultivation Ratio: A subcultivation ratio of 1:2 to 1:3 is recommended
	
	
		Medium Renewal: Every 2 to 3 days
	
	
		Remove medium, and rinse with 0.25% trypsin, 0.03% EDTA solution. Remove the solution and add an additional 1 to 2 ml of trypsin-EDTA solution. Hs 889.T細胞Allow the flask to sit at room temperature (or at 37C) until the cells detach.
	
	
		Add fresh culture medium, aspirate and dispense into new culture flasks.
	
	
		Preservation:	culture medium 95%; DMSO, 5%
	
	
		Related Products:	Recommended medium (without the additional supplements or serum described under ATCC Medium):ATCC 30-2002
	
	
		recommended serum:ATCC 30-2020